Lepromatous leprosy

MONDO:0005127

A chronic communicable infection which is a principal or polar form of leprosy. This disorder is caused by mycobacterium leprae and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage.

Also known as: lepromatous leprosy [type L]

3 clinical trials for this condition and its sub-types, 3 tagged with Lepromatous leprosy itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Leprosy (12)

Including sub-types (3) Tagged with Lepromatous leprosy (3)

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for leprosy patients: experimental drug dovramilast under trial

Disease control Recruiting now

This study tests an experimental drug called dovramilast in 45 adults with moderate to severe leprosy type 2 reaction, a painful skin condition. Participants receive either dovramilast (100 mg or 150 mg) or standard treatments like prednisolone or thalidomide. The goal is to see …

Phase 2 • Sponsor: Medicines Development for Global Health • Aim: Disease control

Last updated Sep 04, 2026 00:00 UTC

Lepromatous leprosy

Where it sits in the disease tree

New hope for leprosy patients: experimental drug dovramilast under trial